Does BLONANSERIN Cause Salivary hypersecretion? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Salivary hypersecretion have been filed in association with BLONANSERIN. This represents 3.6% of all adverse event reports for BLONANSERIN.
9
Reports of Salivary hypersecretion with BLONANSERIN
3.6%
of all BLONANSERIN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Salivary hypersecretion From BLONANSERIN?
Of the 9 reports, 3 (33.3%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLONANSERIN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does BLONANSERIN Cause?
Drug ineffective (21)
Schizophrenia (21)
Somnolence (21)
Hallucination, auditory (18)
Off label use (16)
Agitation (14)
Pneumonia aspiration (14)
Psychiatric symptom (14)
Insomnia (12)
Parkinsonism (12)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which BLONANSERIN Alternatives Have Lower Salivary hypersecretion Risk?
BLONANSERIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLONANSERIN vs BOCEPREVIR
BLONANSERIN vs BOCOCIZUMAB
BLONANSERIN vs BONIVA
BLONANSERIN vs BONVIVA